<?xml version="1.0" encoding="UTF-8"?>
<ref id="B139">
 <label>139</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hoffmann</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Schroeder</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Kleine-Weber</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Müller</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Drosten</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Pöhlmann</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>Nafamostat mesylate blocks activation of SARS-CoV-2 new treatment option for COVID-19</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2020</year>
  <volume>64</volume>
  <issue>6</issue>
  <fpage>1</fpage>
  <lpage>7</lpage>
 </element-citation>
</ref>
